Roz, “Highly tumorigenic lung cancer CD133+ cells display stem-like features and are spared by cisplatin treatment,” Proceedings of the National Academy of Sciences of the United States of America, vol. 106, no. 38, pp. 16281–16286, 2009.S. P. Hong, J. Wen, S. Bang, S. Park, and S. Y. Song, “CD44-positive cells are responsible for gemcitabine resistance in pancreatic cancer cells,” International Journal of Cancer, vol. 125, no. 10, pp. 2323–2331, 2009.S. J. Dylla, L. Beviglia, and L. Beviglia, “Colorectal cancer stem cells are enriched in xenogeneic tumors following chemotherapy,” PLoS ONE, vol. 3, no. 6, Article ID e2428, 2008.M. R. Loebinger, A. Giangreco, and A. Giangreco, “Squamous cell cancers contain a side population of stem-like cells that are made chemosensitive by ABC transporter blockade,” British Journal of Cancer, vol. 98, no. 2, pp. 380–387, 2008.Q. Zhang, S. Shi, Y. Yen, J. Brown, J. Q. Ta, and A. D. Le, “A subpopulation of CD133+ cancer stem-like cells characterized in human oral squamous cell carcinoma confer resistance to chemotherapy,” Cancer Letters, vol. 289, no. 2, pp. 151–160, 2009.. Może to być powodem nawracania choroby nowotworowej. W związku z tym rakowe komórki macierzyste są potencjalnym celem terapii nowotworowej.